AIDing the immune system-DIAbolic in cancer

Seminars in Immunology

Volumn 24, Issue 4, 2012, Pages 241-245

  Schmitz, Kerstin Maike ^a   Petersen Mahrt, Svend K ^a  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

5mC; AID; APOBEC1; Cancer; DNA deaminases; Mutagenesis

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; APC PROTEIN; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTOSINE; PROTEIN P53; THYMIDINE; URACIL;

ADAPTIVE IMMUNITY; B CELL LYMPHOMA; BREAST CANCER; CARCINOGENESIS; COLON TUMOR; DEAMINATION; DNA REPAIR; GENE MUTATION; HUMAN; KIDNEY CANCER; LUNG SMALL CELL CANCER; MUTAGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVIEW; SKIN CANCER; TRANSCRIPTION REGULATION;

CYTIDINE DEAMINASE; EVOLUTION, MOLECULAR; HUMANS; IMMUNE SYSTEM; NEOPLASMS;

EID: 84865191566     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2012.07.001     Document Type: Review

References (31)

1. Beale R.C., Petersen-Mahrt S.K., Watt I.N., Harris R.S., Rada C., Neuberger M.S. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. Journal of Molecular Biology 2004, 337:585-596.
2. Bhutani N., Brady J.J., Damian M., Sacco A., Corbel S.Y., Blau H.M. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010, 463:1042-1047.
3. Bransteitter R., Pham P., Scharff M.D., Goodman M.F. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:4102-4107.
4. Chaudhuri J., Tian M., Khuong C., Chua K., Pinaud E., Alt F.W. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 2003, 422:726-730.
5. Coker H.A., Petersen-Mahrt S.K. The nuclear DNA deaminase AID functions distributively whereas cytoplasmic APOBEC3G has a processive mode of action. DNA Repair (Amsterdam) 2007, 6:235-243.
6. Conticello S.G., Thomas C.J., Petersen-Mahrt S., Neuberger M.S. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Molecular Biology and Evolution 2005, 22:367-377.
7. Di Noia J.M., Neuberger M.S. Molecular mechanisms of antibody somatic hypermutation. Annual Review of Biochemistry 2007, 76:1-22.
8. Harris R.S., Petersen-Mahrt S.K., Neuberger M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Molecular Cell 2002, 10:1247-1253.
9. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993, 362:709-715.
10. Liu M., Duke J.L., Richter D.J., Vinuesa C.G., Goodnow C.C., Kleinstein S.H., et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008, 451:841-845.
11. Matsumoto Y., Marusawa H., Kinoshita K., Endo Y., Kou T., Morisawa T., et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nature Medicine 2007, 13:470-476.
12. Morgan H.D., Dean W., Coker H.A., Reik W., Petersen-Mahrt S.K. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. Journal of Biological Chemistry 2004, 279:52353-52360.
13. Morgan H.D., Dean W., Coker H.A., Reik W., Petersen-Mahrt S.K. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. The Journal of Biological Chemistry 2004, 279:52353-52360.
14. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
15. Nik-Zainal S., Alexandrov L.B., Wedge D.C., Van Loo P., Greenman C.D., Raine K., et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012, 149:979-993.
16. Pasqualucci L., Neumeister P., Goossens T., Nanjangud G., Chaganti R.S., Kuppers R., et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001, 412:341-346.
17. Pauklin S., Sernandez I.V., Bachmann G., Ramiro A.R., Petersen-Mahrt S.K. Estrogen directly activates AID transcription and function. Journal of Experimental Medicine 2009, 206:99-111.
18. Petersen-Mahrt S.K., Coker H.A., Pauklin S. DNA deaminases: AIDing hormones in immunity and cancer. Journal of Molecular Medicine (Berlin) 2009, 87:893-897.
19. Petersen-Mahrt S.K., Harris R.S., Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 2002, 418:99-103.
20. Petersen-Mahrt S.K., Neuberger M.S. In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1). The Journal of Biological Chemistry 2003, 278:19583-19586.
21. Pleasance E.D., Stephens P.J., O'Meara S., McBride D.J., Meynert A., Jones D., et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010, 463:184-190.
22. Popp C., Dean W., Feng S., Cokus S.J., Andrews S., Pellegrini M., et al. Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 2010, 463:1101-1105.
23. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996, 381:751-758.
24. Ramiro A.R., Jankovic M., Callen E., Difilippantonio S., Chen H.T., McBride K.M., et al. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 2006, 440:105-109.
25. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000, 102:565-575.
26. Robert I., Dantzer F., Reina-San-Martin B. Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination. Journal of Experimental Medicine 2009, 206:1047-1056.
27. Selth L.A., Sigurdsson S., Svejstrup J.Q. Transcript Elongation by RNA Polymerase II. Annual Review of Biochemistry 2010, 79:271-293.
28. Stanlie A., Begum N.A., Akiyama H., Honjo T. The DSIF subunits Spt4 and Spt5 have distinct roles at various phases of immunoglobulin class switch recombination. PLoS Genetics 2012, 8:e1002675.
29. Stavnezer J., Guikema J., Schrader C. Mechanism and regulation of class switch recombination. Annual Review of Immunology 2008, 26:261-292.
30. Stephens P.J., Tarpey P.S., Davies H., Van Loo P., Greenman C., Wedge D.C., et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 2012, 486:400-404.
31. Willmann K., Kracker S., Simon M.T., Franchini D.-M., Gardes P., Durandy A., et al. AID in immunodeficiency and cancer. DNA Deamination and the Immune System 2010, Imperial College Press, London. S. Fugmann, M. Diaz, F.N. Papavasiliou (Eds.).